1. Market Research
  2. > Healthcare Market Trends
Soft Tissue Allografts Market - Growth, Trends, Covid-19 Impact, and Forecasts (2021 - 2026)

Soft Tissue Allografts Market - Growth, Trends, Covid-19 Impact, and Forecasts (2021 - 2026)

  • March 2021
  • 133 pages
  • ID: 6039497
  • Format: PDF
  • Mordor Intelligence LLP

Summary

Table of Contents

Search Inside

The Global Soft Tissue Allografts Market was valued at USD 3,077.43 million in 2020, and it is expected to reach USD 4,724.46 million by 2026, registering a CAGR of 6.75% during the period of 2021-2026.

The outbreak of COVID-19 resulted in decreased public mobility and significantly impacted the therapeutic and surgical procedures, as the surgical procedures that are non-immediate and are being postponed to decrease the burden on healthcare infrastructure.

The outbreak of COVID-19 worldwide showed an impact on the market studied as surgical procedures kept on hold in order to prevent the spread of the COVID-19 virus. There is tremendous pressure on the hospitals and other healthcare centers in providing services to COVID-19 patients is also one of the factors that are inhibiting the hospitals in providing services.

The rising demand for soft tissue allografts in athletics and other sports is contributing largely to the market growth. Modern training regimens in athletics, field events, and a number of other contact sports like American football, require athletes to undergo intensive training sessions which are in practice more strenuous than the actual sport itself.

High-intensity training regimens are directly correlated with athletic performance improvement but excessive training also induces muscle and bone fatigue and often leads to injury. Consequently, injury prevalence among athletes has been increasing especially due to excessive training. The competitive nature of sports has spurred the demand among athletes for quick recovery and easily accessible modalities to treat musculoskeletal injuries.

Furthermore, osteoarthritis has a considerable impact on the individual patient, resulting in pain & disability, and the increasing prevalence of this diseases is expected to boost the market in near future.

For instance, as per data from the U.S. Department of Health and Human Services, 2018 reports an estimated 8.6 million sports injuries occur each year. The soft tissue market finds its grip behind technology development. While many companies in the market would like to release products that help market growth, awareness and growth in learning levels about these products will also play a big role. The level of awareness among the public, especially with the increase in internet access and easy access to social media, has increased. Over time, the soft tissue market will benefit from growing knowledge about products and processes.

Thus, demand for soft tissue allografts has been increasing in athletics and other contact sports, which in turn is fuelling the growth of the global soft tissue allografts market.

Key Market Trends
Cartilage Allograft is Expected to Hold Significant Market Share Over the Forecast Period

Cartilage allografts are the vital components in orthopedic surgical procedures such as joint reconstruction etc. Cartilage graft transplantation is frequently used in the treatment of chondral and osteochondral lesions, most commonly in the knee. These procedures can serve to improve the quality of life for those with pathology of the cartilage within joints and alleviate symptoms.

According to Ann Med Surg in his article published in 2020, estimate of the orthopedic surgery cancellation rate was approximately 82.0%, representing 6,295,041 of 7,677,515 cases. They concluded that if countries increased their normal surgical volumes by 20% after the pandemic, it would take about 45 weeks to clear the backlog of operations resulting from the disruption caused by COVID-19.

The scientific basis of Osteochondral allograft (OCA) is the transplantation of fully developed, or mature hyaline (joint) cartilage containing living cartilage cells (‘chondrocytes’) that survive the transplant and support the production of the cartilage matrix indefinitely.

As per the 2019 article published on Journal of Bone & Joint Surgery, Inc. by the researchers from Ohio State University College of Medicine, the conclusion of the study demonstrated that Osteochondral allograft (OCA) transplantation is a versatile treatment option for patients with cartilage and osteochondral defects and it is a uniquely useful treatment option for patients with large high-grade osteochondral defects and for athletes who have substantial incentives to return to sport as quickly as possible.

Arthrex, Inc. is one of the most renowned company involved in development of cartilage allografts. The company’s portfolio includes several cartilage allografts namely Arthrex Meniscal Allograft Arthroplasty, Small Joint OATS (Osteochondral Autograft Transfer System) amongst others.

In March 2019, MTF Biologics expanded its portfolio with the launch of CartiMax viable cartilage allograft. CartiMax is a putty-like cartilage allograft designed to easily fill lesions in the knee, foot and ankle.

Thus, owing to the aforementioned factors, the market for Cartilage allografts segment is expected to grow significantly during the forecast period.

North America is Expected to Dominate the Market Over the Forecast Period

In North America, the market growth is majorly driven by factors, such as increasing prevalence of diabetic foot ulcers, better healthcare awareness program for diabetes, and an increasing number of surgical procedures on anterior cruciate ligament (ACL).

During COVID-19 pandemic 2020, in North America region, the specialty clinics, including dental practices and hospitals were shut down or their operations were limited, and some hospitals were being converted to containment facilities and treatment wards for COVID-19 patients.

In March 2020, in the United States, National Association for the Advancement of Orthotics and Prosthetics (NAAOP) issued an alert in which it was made clear that during the COVID-19 national emergency, state and local health authorities should consider orthotic and prosthetic practices as essential providers that must remain accessible to patients in need of orthotic and prosthetic care.

According to the Canadian Institute for Health Information 2019 report, the number of Canadians having joint replacements has increased over the past 5 years, with 130,000 surgeries being performed annually. There were almost 59,000 hip replacements and more than 70,000 knee replacements that were performed in Canada in 2017–2018. This represents an increase of 17.4% and 17%, respectively, over the last 5 years.

Therefore, the rising burden of diseases is creating tremendous opportunities for market players, and they are focusing on R&D activities, in order to bring new & reliable products in the market, thus, driving the market growth. For instance, In Feb 2020, Integra LifeSciences Holding Corporation has made the launch of AmnioExcel Plus Placental Allograft Membrane, that is the latest wound care offering to support soft tissue repair. Thus, owing to the aforementioned factors the market is expected to witness a high growth rate, over the forecast period.

Competitive Landscape
The Soft Tissue Allografts Market is moderately competitive and many of the global players are into the market. Some of the market players include Abbvie inc. (Allergan), Conmed Corporation, Becton Dickinson and Company, Smith & Nephew (Osiris Therapeutics Inc.), Integra LifeSciences Corporation, Stryker Corporation, Zimmer Biomet, Arthrex Inc., Direct Biologics and others. Also, new product launches from these players are augmenting the demand for these products.

Reasons to Purchase this report:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Medical Engineered Materials Market by Type, Application And Region - Global Forecast to 2025

  • $ 4950
  • April 2021
  • 220 pages

The global medical engineered materials market size is projected to reach USD 29.1 billion by 2025 from USD 15.8 billion in 2020, at a CAGR of 13.0%. This growth is attributed to the increasing healthcare ...

  • World
  • Europe
  • Healthcare
  • Wound Care
  • Industry analysis
  • Health Expenditure
  • Medical Technology Density

ref:plp2021

Reportlinker.com © Copyright 2021. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on